Cholangiocarcinoma surveillance in PSC: What should we do now and what’s coming next?
Discover how clinicians are approaching screening and surveillance in PSC today. From imaging and endoscopy to the promise of new biomarkers, this episode highlights key tools, ongoing challenges, and future directions in improving early detection of cholangiocarcinoma.
Host: Debbie Shawcross (King's College London)
Guests: Jesús Bañales (Donostia University Hospital), Gideon Hirschfield (The Autoimmune and Rare Liver Disease Programme)
Prefer to listen on the go? This episode is also available on the following streaming platforms:
Talk Liver To Me is supported by Boehringer Ingelheim, GSK, IPSEN and Opella. Boehringer Ingelheim, GSK, IPSEN and Opella have had no input to the content of this programme.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
COI - Speakers have reported the following potential conflicts of interest: Debbie Shawcross: None Jesús Bañales: None Gideon Hirschfield: None
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
